Overview: Protein Electrophoresis Serum Panel
Introduction: The Protein Electrophoresis Serum Panel is a diagnostic tool designed to assess serum protein fractions using serum samples. In India, serum protein electrophoresis is essential for detecting monoclonal gammopathies (multiple myeloma, MGUS) in ~10,000-15,000 new myeloma cases/year, showing M-spike in gamma region. High morbidity from under-testing in rural/low-SES elderly with bone pain, anemia, or renal failure, limited electrophoresis labs, delayed diagnosis leading to progression or complications. Per hematology practices aligned with ICMR and Indian Society of Haematology & Blood Transfusion guidelines, the test employs electrophoresis for total protein, albumin, alpha-1/2, beta-1/2, gamma globulins, A/G ratio, and M-protein over 1-2 days with high accuracy, valuable for identifying paraproteins. This diagnostic falls under protein screening and targets patients with unexplained anemia, hypercalcemia, or renal impairment, addressing accurate detection to guide immunofixation or bone marrow biopsy. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise protein fraction analysis and reducing myeloma burden. Its serum-based approach ensures reliable pattern interpretation.
Other Names: Protein Elec S Pnl.
FDA Status: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.
Historical Milestone: Serum electrophoresis standard in gammopathies; in India, routine in hematology.
Purpose: The test assesses 9 parameters including total protein to guide protein screening, detect M-protein, inform myeloma workup.
Test Parameters: 1. Total Protein, 2. Albumin, 3. Alpha-1 Globulin, 4. Alpha-2 Globulin, 5. Beta-1 Globulin, 6. Beta-2 Globulin, 7. Gamma Globulin, 8. A/G Ratio, 9. M-Protein.
Pretest Condition: Fasting 10-12 hours recommended; patients should have anemia or bone pain.
Specimen: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.
Sample Stability at Room Temperature: 8 hours with proper handling to preserve protein integrity, ensuring reliable test performance.
Sample Stability at Refrigeration: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.
Medical History: Patients should provide details on symptoms, family history.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of undetected gammopathy including progression, benefits of screening, and minimal discomfort from venipuncture.
Procedural Considerations: The test involves sample processing using electrophoresis by trained personnel to ensure sterile technique and interpret patterns within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: M-spike in gamma region indicates monoclonal gammopathy, necessitating specialist input.
Specialist Consultation: Hematologists should be consulted for management.
Additional Supporting Tests: Immunofixation, urine electrophoresis for confirmation.
Test Limitations: Requires immunofixation for typing; comprehensive approach required.
References: Indian Journal of Hematology 2024, Myeloma Studies India 2023.
